These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 21626729)

  • 1. Proceedings of the 2nd International Symposium on Chylomicrons in Disease-2 (ISCD2). June 2-5, 2010. Rotterdam, The Netherlands.
    Atheroscler Suppl; 2010 Jun; 11(1):1-64. PubMed ID: 21626729
    [No Abstract]   [Full Text] [Related]  

  • 2. Progress in understanding postprandial dyslipidaemia: Second International Symposium on the Role of Chylomicrons in Disease l.
    Watts GF; Ribalta J
    Atheroscler Suppl; 2010 Jun; 11(1):1-2. PubMed ID: 20462806
    [No Abstract]   [Full Text] [Related]  

  • 3. Glucagon-Like Peptide 2 (GLP-2) Stimulates Postprandial Chylomicron Production and Postabsorptive Release of Intestinal Triglyceride Storage Pools via Induction of Nitric Oxide Signaling in Male Hamsters and Mice.
    Hsieh J; Trajcevski KE; Farr SL; Baker CL; Lake EJ; Taher J; Iqbal J; Hussain MM; Adeli K
    Endocrinology; 2015 Oct; 156(10):3538-47. PubMed ID: 26132919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of intestinal lipoprotein overproduction in insulin resistant humans.
    Duez H; Pavlic M; Lewis GF
    Atheroscler Suppl; 2008 Sep; 9(2):33-8. PubMed ID: 18676184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paraoxonase 1 (PON1) is present in postprandial chylomicrons.
    Fuhrman B; Volkova N; Aviram M
    Atherosclerosis; 2005 May; 180(1):55-61. PubMed ID: 15823275
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postprandial dyslipidemia in insulin resistance: mechanisms and role of intestinal insulin sensitivity.
    Hsieh J; Hayashi AA; Webb J; Adeli K
    Atheroscler Suppl; 2008 Sep; 9(2):7-13. PubMed ID: 18653387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Postprandial accumulation of chylomicrons and chylomicron remnants is determined by the clearance capacity.
    Adiels M; Matikainen N; Westerbacka J; Söderlund S; Larsson T; Olofsson SO; Borén J; Taskinen MR
    Atherosclerosis; 2012 May; 222(1):222-8. PubMed ID: 22365426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macronutrient intake and modulation on chylomicron production and clearance.
    Lairon D
    Atheroscler Suppl; 2008 Sep; 9(2):45-8. PubMed ID: 18595783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary cholesterol is secreted in intestinally derived chylomicrons during several subsequent postprandial phases in healthy humans.
    Beaumier-Gallon G; Dubois C; Senft M; Vergnes MF; Pauli AM; Portugal H; Lairon D
    Am J Clin Nutr; 2001 May; 73(5):870-7. PubMed ID: 11333839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-based assay to quantify the antioxidant effect of food-derived carotenoids enriched in postprandial human chylomicrons.
    Sánchez-Campillo M; Pérez-Llamas F; González-Silvera D; Martínez-Tomás R; Burgos MI; Wellner A; Avilés F; Parra S; Bialek L; Alminger M; Larqué E
    J Agric Food Chem; 2010 Oct; 58(20):10864-8. PubMed ID: 20925314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chylomicronemia, fat tolerance, and atherosclerosis.
    Moreton JR
    Int J Epidemiol; 2016 Oct; 45(5):1372-1379. PubMed ID: 27581801
    [No Abstract]   [Full Text] [Related]  

  • 12. Mechanisms of postprandial hyperlipidaemia--remnants and coronary artery disease.
    Karpe F
    Diabet Med; 1997 Aug; 14 Suppl 3():S60-6. PubMed ID: 9272616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal scavenger receptor class B type I as a novel regulator of chylomicron production in healthy and diet-induced obese states.
    Lino M; Farr S; Baker C; Fuller M; Trigatti B; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2015 Sep; 309(5):G350-9. PubMed ID: 26138463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are we ready for a prospective study to investigate the role of chylomicrons in cardiovascular disease?
    Cohn JS
    Atheroscler Suppl; 2008 Sep; 9(2):15-8. PubMed ID: 18585099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chylomicrons in disease-future challenges Invited keynote address.
    Redgrave TG
    Atheroscler Suppl; 2008 Sep; 9(2):3-6. PubMed ID: 18585100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial chylomicrons and adipose tissue lipoprotein lipase are altered in type 2 diabetes independently of obesity and whole-body insulin resistance.
    Annuzzi G; Giacco R; Patti L; Di Marino L; De Natale C; Costabile G; Marra M; Santangelo C; Masella R; Rivellese AA
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):531-8. PubMed ID: 18321693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incretin-based therapies for treatment of postprandial dyslipidemia in insulin-resistant states.
    Farr S; Adeli K
    Curr Opin Lipidol; 2012 Feb; 23(1):56-61. PubMed ID: 22123671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influence of peripheral tissues on chylomicrons in blood. II. Behavior of the postprandial arteriovenous residue of chylomicrons during the pharmacological action of nicotinic acid].
    CORDOVA C; D'ARRIGO C; PALMA G
    Boll Soc Ital Biol Sper; 1956 Jun; 32(6):331-4. PubMed ID: 13374073
    [No Abstract]   [Full Text] [Related]  

  • 19. [Influence of peripheral tissues on chylomicrons in blood. III. Variations in the postprandial arteriovenous residue of chylomicrons by the effect of local thermal stimulations (hot and cold)].
    CORDOVA C; D'ARRIGO C; PALMA G
    Boll Soc Ital Biol Sper; 1956 Jun; 32(6):334-7. PubMed ID: 13374074
    [No Abstract]   [Full Text] [Related]  

  • 20. Intestinally derived lipids: metabolic regulation and consequences--an overview.
    Cianflone K; Paglialunga S; Roy C
    Atheroscler Suppl; 2008 Sep; 9(2):63-8. PubMed ID: 18693144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.